Important Notice: Our web hosting provider recently started charging us for additional visits, which was unexpected. In response, we're seeking donations. Depending on the situation, we may explore different monetization options for our Community and Expert Contributors. It's crucial to provide more returns for their expertise and offer more Expert Validated Answers or AI Validated Answers. Learn more about our hosting issue here.

Why is MAPS focused on posttraumatic stress disorder (PTSD) and anxiety associated with life-threatening illnesses?

April 26, 2017anxiety associated disorder focused illnesses life-threatening Maps posttraumatic PTSD stress

0

Posted

Why is MAPS focused on posttraumatic stress disorder (PTSD) and anxiety associated with life-threatening illnesses?

1 Answer

0

Posted

In order to develop psychedelics into prescription medicines there must be a medical condition the medicine is treating. We are investigating treating PTSD and anxiety associated with terminal illnesses because of reports of successful treatments by pioneers of psychedelic research. We estimate that it will take ten years and $10 million to turn one substance into a prescription medicine. We have chosen MDMA/PTSD research as our top priority project because we believe we can most efficiently achieve this goal.